Literature DB >> 1027412

Mechanism of thyroid allograft rejection.

K J Lafferty, A Bootes, V A Killby, W Burch.   

Abstract

Balb/c thyroids, held in organ culture for 26 days, survive and function as well as isografts for greater than 100 days in CBA recipients. Uncultured allografts are totally rejected by 20 days after transplantation. Prolonged allograft survival can also be achieved by the treatment of donor animals with cyclophosphamide prior to harvesting tissues for transplantation. These allografts do not survive as well as 26 day cultured allografts, but cyclophosphamide pretreatment reduces the culture time required to achieve indefinite survival to 7 days. The provision of an allogeneic (LD) stimulus by thyroid tissue that is I-region incompatible with the host does not facilitate the rejection of a tolerated cultured allograft. However, activation of the host immune system by an uncultured graft syngeneic to a tolerated cultured allograft leads to the chronic rejection of the cultured transplant. The transfer of a tolerated cultured allograft back to its strain of origin induces an acute inflammatory reaction that causes tissue damage within the transplant but does not lead to the total destruction of the tissue.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1027412     DOI: 10.1038/icb.1976.58

Source DB:  PubMed          Journal:  Aust J Exp Biol Med Sci        ISSN: 0004-945X


  6 in total

1.  Theory and practice of immunoregulation by tissue treatment prior to transplantation.

Authors:  K J Lafferty; S J Prowse
Journal:  World J Surg       Date:  1984-04       Impact factor: 3.352

Review 2.  Mechanism of cellular rejection in transplantation.

Authors:  Elizabeth Ingulli
Journal:  Pediatr Nephrol       Date:  2010-01       Impact factor: 3.714

3.  Toxoplasma gondii antigen-pulsed-dendritic cell-derived exosomes induce a protective immune response against T. gondii infection.

Authors:  Fleur Aline; Daniel Bout; Sébastian Amigorena; Philippe Roingeard; Isabelle Dimier-Poisson
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

4.  Evidence for major histocompatibility complex restriction in transplantation immunity.

Authors:  W K Silvers; H L Fleming; A Naji; C F Barker
Journal:  Proc Natl Acad Sci U S A       Date:  1982-01       Impact factor: 11.205

5.  Pancreatic islet transplantation--experimental experience and clinical potential.

Authors:  K J Lafferty
Journal:  West J Med       Date:  1985-12

6.  Influence of culturing on the survival of major histocompatibility complex-compatible and -incompatible thyroid grafts in rats.

Authors:  S T Bartlett; A S Jennings; C Yu; A Naji; C F Barker; W K Silvers
Journal:  J Exp Med       Date:  1983-01-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.